Intermittent parathyroid hormone 1-34 induces oxidation and deterioration of mineral and collagen quality in newly formed mandibular bone

被引:6
作者
Yoshioka, Yohsuke [1 ]
Yamachika, Eiki [2 ]
Nakanishi, Makoto [3 ]
Ninomiya, Tadashi [4 ]
Akashi, Sho [1 ]
Kondo, Sei [1 ]
Moritani, Norifumi [1 ]
Kobayashi, Yasuhiro [5 ]
Fujii, Tatsuo [3 ]
Iida, Seiji [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan
[2] Okayama Univ Hosp, Dept Oral & Maxillofacial Reconstruct Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan
[3] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Appl Chem, Kita Ku, 1-1-1 Tsushima Naka, Okayama, Japan
[4] Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo, Japan
[5] Matsumoto Dent Univ, Inst Oral Sci, Div Hard Tissue Res, 1780 Gobara Hirooka, Nagano, Japan
关键词
OSTEOPOROSIS; MECHANISMS; INCREASES; MELATONIN; STRENGTH; IMPLANTS; THERAPY;
D O I
10.1038/s41598-019-44389-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intermittent parathyroid hormone (PTH) administration is known to promote bone healing after surgical procedures. However, the mechanism and influence of PTH on the mineral and collagen quality of the jaw are not well understood. Most studies have focused on analyzing the bone density and microstructure of the mandible, and have insufficiently investigated its mineral and collagen quality. Oxidative stress activates osteoclasts, produces advanced glycation end products, and worsens mineral and collagen quality. We hypothesized that PTH induces oxidation and affects the mineral and collagen quality of newly formed mandibular bone. To test this, we examined the mineral and collagen quality of newly formed mandibular bone in rats administered PTH, and analyzed serum after intermittent PTH administration to examine the degree of oxidation. PTH administration reduced mineralization and worsened mineral and collagen quality in newly formed bone. In addition, total anti-oxidant capacity in serum was significantly decreased and the oxidative-INDEX was increased among PTH-treated compared to vehicle-treated rats, indicating serum oxidation. In conclusion, intermittent administration of PTH reduced mineral and collagen quality in newly formed mandibular bone. This effect may have been induced by oxidation.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Single-dose local administration of parathyroid hormone (1-34, PTH) with -tricalcium phosphate/collagen (-TCP/COL) enhances bone defect healing in ovariectomized rats
    Tao, Zhou-Shan
    Zhou, Wan-Shu
    Wu, Xin-Jing
    Wang, Lin
    Yang, Min
    Xie, Jia-Bing
    Xu, Zhu-Jun
    Ding, Guo-Zheng
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (01) : 28 - 35
  • [32] Parathyroid hormone [1-34] improves articular cartilage surface architecture and integration and subchondral bone reconstitution in osteochondral defects in vivo
    Orth, P.
    Cucchiarini, M.
    Zurakowski, D.
    Menger, M. D.
    Kohn, D. M.
    Madry, H.
    OSTEOARTHRITIS AND CARTILAGE, 2013, 21 (04) : 614 - 624
  • [33] Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing
    Morgan, Elise F.
    Mason, Zachary D.
    Bishop, Gavin
    Davis, A. David
    Wigner, Nathan A.
    Gerstenfeld, Louis C.
    Einhorn, Thomas A.
    BONE, 2008, 43 (06) : 1031 - 1038
  • [34] Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur
    Tao, Zhou-Shan
    Zhou, Wan-Shu
    Qiang, Zhou
    Tu, Kai-kai
    Huang, Zheng-Liang
    Xu, Hong-Ming
    Sun, Tao
    Lv, Yang-Xun
    Cui, Wei
    Yang, Lei
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2016, 30 (07) : 952 - 960
  • [35] Parathyroid hormone PTH(1-34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits
    Aleksyniene, Ramune
    Thomsen, Jesper Skovhus
    Eckardt, Henrik
    Bundgaard, Kristian G.
    Lind, Martin
    Hvid, Ivan
    ACTA ORTHOPAEDICA, 2009, 80 (06) : 716 - 723
  • [36] Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment
    Miki, T
    Nakatsuka, K
    Naka, H
    Masaki, H
    Imanishi, Y
    Ito, M
    Inaba, M
    Morii, H
    Nishizawa, Y
    JOURNAL OF BONE AND MINERAL METABOLISM, 2004, 22 (06) : 569 - 576
  • [37] Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment
    Takami Miki
    Kiyoshi Nakatsuka
    Hiroshi Naka
    Hideki Masaki
    Yasuo Imanishi
    Masako Ito
    Masaaki Inaba
    Hirotoshi Morii
    Yoshiki Nishizawa
    Journal of Bone and Mineral Metabolism, 2004, 22 : 569 - 576
  • [38] Parathyroid Hormone (1-34) Augments Spinal Fusion, Fusion Mass Volume, and Fusion Mass Quality in a Rabbit Spinal Fusion Model
    O'Loughlin, Padhraig F.
    Cunningham, Matthew E.
    Bukata, Susan V.
    Tomin, Emre
    Poynton, Ashley R.
    Doty, Stephen B.
    Sama, Andrew A.
    Lane, Joseph M.
    SPINE, 2009, 34 (02) : 121 - 130
  • [39] MODULATION OF THE ANABOLIC EFFECT OF SYNTHETIC HUMAN PARATHYROID-HORMONE FRAGMENT-(1-34) IN THE BONE OF GROWING RATS BY VARIATIONS IN THE DOSAGE REGIMEN
    RIOND, JL
    CLINICAL SCIENCE, 1993, 85 (02) : 223 - 228
  • [40] Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface
    Li, Y. F.
    Li, X. D.
    Bao, C. Y.
    Chen, Q. M.
    Zhang, H.
    Hu, J.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (03) : 1063 - 1071